Information about Giura Pharma
My details
*
*
*

Giura Pharma (SRL)

BE 0692.655.422

Heidelaan 25, 2580 Putte

Company information

Status
Active

Enterprise number

BE0692.655.422

VAT liability
Yes
Established
19-03-2018
Last balance sheet year
2024
Company size
Small 0 FTE
Principal activity
Activities of holding companies
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Giura Pharma

2024 2023 2022 2021
Profit/Loss € 72,134 -11 % € 80,938 20 % € 67,682 24 % € 54,761
Equity € 380,436 23 % € 308,302 36 % € 227,364 42 % € 159,682
Gross margin € 109,673 -12 % € 124,791 17 % € 106,424 20 % € 88,923

Publications from Giura Pharma

Date Publication
12-12-2023 Articles of Association (Translation, Coordination, Other Modifications, …) - Modification Legal Form - Resignations - Appointments (NL)
21-03-2018 Rubric Constitution (New Juridical Person, Opening Branch, etc...) (NL)

Frequently asked questions

What is the VAT number of Giura Pharma?
The VAT number of Giura Pharma is BE 0692.655.422.
Wat is the PEPPOL ID of Giura Pharma?
The PEPPOL ID of Giura Pharma is 0208:0692655422. Log in or start a free trial to see the full overview.
When was Giura Pharma founded?
Giura Pharma was founded on 19-03-2018.
What is the address of Giura Pharma?
The current registered office of Giura Pharma is located at Heidelaan 25, 2580 Putte.
When was the last time Giura Pharma filed their annual financial statements?
The most recent financial statements of Giura Pharma were filed on 07-07-2025.
How many employees does Giura Pharma have?
There are currently no employees working at Giura Pharma or no workforce information is available.
What is the annual turnover of Giura Pharma?
At the time of its most recent financial statements, Giura Pharma did not publish any turnover figures. Giura Pharma reported a gross margin of €109,673.14.

Sources